Gallstones & Gallbladder Health: A Nutritional and Natural-Health Reference
1. Definition and Overview
Cholelithiasis is the name clinicians commonly use for gallstones. The biliary tract — made up of the gallbladder and bile ducts — assists digestion by releasing bile; the gallbladder itself is a small, pear-shaped organ located in the upper right abdomen, below the liver. The liver produces bile, which is mostly made of cholesterol, bile salts, and bilirubin; the gallbladder stores this bile until it is needed, and when a person eats, the body signals the gallbladder to empty bile into the duodenum to mix with food.
Gallstones are composed of a mixture of cholesterol, calcium salts of bilirubinate or palmitate, proteins, and mucin; based upon the predominant constituents, they are broadly classified as cholesterol stones — which usually form in individuals with a genetic or environmental predisposition to bile that is supersaturated with cholesterol — or pigment stones. Cholesterol gallstones are found in more than 80% of patients with gallstone disease, and the pathogenesis involves both local (gallbladder and bile) and systemic factors.
Stones vary in size and shape from as small as a grain of sand to as large as a golf ball. Black pigment stones are more common in patients with cirrhosis or chronic hemolytic conditions such as the thalassemias, hereditary spherocytosis, and sickle cell disease, in which bilirubin excretion is increased. Primary bile-duct stones, defined as stones that originate in the bile ducts, are usually brown pigment stones associated with infection; bacteria in the biliary system release β-glucuronidases, which hydrolyze glucuronic acid from conjugated bilirubin, and the resulting unconjugated bilirubin precipitates as its calcium salts.
2. Body Systems Involved
Complications of gallstones may affect the pancreatic, biliary, hepatic, or gastrointestinal systems, making them a leading cause of gastrointestinal disorders in the United States. The hepatobiliary system — encompassing the liver, gallbladder, bile ducts, and pancreas — is the primary anatomical domain affected.
Common abnormalities of the hepatobiliary system in gallstone patients include accelerated nucleation, gallbladder hypomotility, and the accumulation of mucin gel; unphysiologic supersaturation, generally from hypersecretion of cholesterol, is essential for the formation of cholesterol gallstones. From an epidemiologic point of view, the risk of gallstones has been associated with higher risk of incident ischemic heart disease, total mortality, and disease-specific mortality independently from traditional risk factors such as body weight, lifestyle, diabetes, and dyslipidemia — evidence pointing to the existence of complex pathogenic pathways linking gallstones to altered systemic homeostasis involving multiple organs.
Additional factors in the pathogenesis include mucin and inflammatory changes in the gallbladder, slow intestinal motility, increased intestinal absorption of cholesterol, and altered gut microbiota; mechanisms of disease are linked with insulin resistance, obesity, the metabolic syndrome, and type 2 diabetes, and the role of nuclear receptors, signaling pathways, gut microbiota, and the epigenome are being actively investigated.
Elevated levels of pro-inflammatory proteins such as interleukin-6 (IL-6), IL-10, IL-12(p70), and IL-13 appear to be associated with the risk of gallstones.
3. Clinical Presentation
Gallstones often remain asymptomatic, detected incidentally during imaging, but can lead to significant complications such as biliary colic, acute cholecystitis, cholangitis, or pancreatitis. While often asymptomatic, gallstone disease can manifest as chronic pain, episodic discomfort, nausea, upper abdominal colic, diarrhea, and anorexia.
Biliary colic manifests as intermittent right upper abdominal pain, often triggered by greasy or spicy foods, due to gallbladder contraction against obstructing stones. Acute cholecystitis often involves more severe, at times unrelenting pain, and a mass may be palpated in the right upper quadrant; the affected person may be febrile and tachycardic, and those with common duct obstruction may be jaundiced. Gallstone obstruction in the proximity of the pancreatic duct may cause acute pancreatitis with symptoms of mid-epigastric pain and intractable vomiting. Ascending cholangitis, involving bacterial infiltration of the biliary system, presents with right upper quadrant pain, fever, and jaundice — the classic Charcot triad.
Approximately 10% of asymptomatic patients develop symptoms within five years of diagnosis and 20% within 20 years.
4. Epidemiology
Gallstone disease (GSD) represents one of the most common digestive system disorders worldwide, with increasing prevalence rates approaching 6% of the global population; the geographic distribution shows significant variation, with traditionally lower rates in Asian countries now experiencing rapid upward trends. Gallstones are common with prevalences as high as 60% to 70% in American Indians and 10% to 15% in white adults of developed countries; ethnic differences abound with a reduced frequency in black Americans and those from East Asia, while being rare in sub-Saharan Africa.
Results from global epidemiological studies suggest that different economic development levels partly explain these geographic differences, which are likely linked to several key gallstone risk factors such as high-calorie diets and obesity. More than 20% of women and 8% of men develop gallstones at some time in their lives.
5. Contributing and Associated Factors
5.1 Non-Modifiable Risk Factors
Certain risk factors for gallstones are immutable: female gender, increasing age, and ethnicity and family (genetic) traits. Women are more likely to develop gallstones than men. In one association study, significant risk factors for symptomatic gallstone disease included female gender (relative risk 8.8), obesity (BMI >30; relative risk 3.7), and age >50 (relative risk 2.5).
Data from genetic studies suggest that genetic factors are responsible for at least 30% of symptomatic gallstone disease; however, the true role of heredity in gallstone pathogenesis is probably higher, because data based on symptomatic gallbladder disease underestimates the true prevalence in the population.
5.2 Metabolic and Disease-Related Factors
Increasing age, familial history of the disease, unhealthy lifestyle, overweight, dyslipidemia, type 2 diabetes, and high plasma insulin levels are all associated with gallstones. Risk factors of cholesterol gallstones share some common pathogenic pathways across major metabolic abnormalities, including insulin resistance, with those in obesity, the metabolic syndrome, and type 2 diabetes.
Obesity is an important risk factor for gallstone disease, more so for women than for men; it raises the risk of cholesterol gallstones by increasing biliary secretion of cholesterol as a result of an increase in HMG-CoA reductase activity. Spinal cord injury raises gallstone risk due to decreased gallbladder motility leading to gallbladder stasis and decreased intestinal transit; cirrhosis is a risk factor for pigment gallstones, with only a small proportion of cirrhotic patients having cholesterol stones, with increased risk possibly due to reduced hepatic synthesis of bile salts, high estrogen levels, and impaired gallbladder contraction in response to a meal.
A comprehensive 2025 review highlighted the intricate relationship between metabolic syndrome and gallstone disease, focusing on the role of insulin resistance, dyslipidemia, obesity, and gut microbiota dysbiosis in gallstone formation, linking metabolic disturbances to bile cholesterol supersaturation, gallbladder dysmotility, and chronic inflammation.
5.3 Medications and Other Clinical Factors
Modifiable risk factors include obesity, the metabolic syndrome, rapid weight loss, certain diseases (cirrhosis and Crohn's disease), gallbladder stasis from spinal cord injury or drugs such as somatostatin, and lifestyle. Well-defined risk factors also include tobacco smoking, which has been shown in multiple observational studies to increase the risk of developing gallbladder disease.
6. Dietary Factors: Evidence from Research
6.1 Overall Dietary Patterns
Dietary models characterized by increased energy intake with highly refined sugars and sweet foods, high fructose intake, low fiber content, high fat, consumption of fast food, and low vitamin C intake increase the risk of gallstone formation. Conversely, high intake of monounsaturated fats and fiber, olive oil and fish (omega-3 fatty acids) consumption, vegetable protein intake, fruit, coffee, moderate alcohol consumption, and vitamin C supplementation exert a protective role.
Prospective cohort studies, meta-analyses, and Mendelian randomization analyses have found that high intake of ultra-processed foods, sugar-sweetened beverages, and refined carbohydrates was consistently associated with an increased risk of gallstone disease, while plant-based diets emphasizing whole and minimally processed foods, high fruit and vegetable consumption, and anti-inflammatory dietary patterns showed protective effects; vegetarian diets appeared particularly beneficial for women.
A large-scale prospective cohort study indicates that adherence to the Alternative Mediterranean Diet score (aMED) and the 2015 Healthy Eating Index (HEI-2015) dietary patterns can reduce the risk of gallstone disease by 10%.
6.2 Dietary Fat
Consumption of simple sugars and saturated fat has been mostly associated with a higher risk of gallstone disease, while fiber intake and moderate consumption of alcohol consistently reduce the risk. A systematic review reported a significant risk factor of cholelithiasis in high intake of animal fats, meat, and fried foods, and significant protection against cholelithiasis in high intake of fruits, nuts, fish, monounsaturated fat/saturated fat ratio (MUFA/SFA), omega-3 fatty acids, and vegetables.
In a population-based case-control study from southern Italy, BMI and intake of refined sugars were directly associated with risk of gallstone formation, whereas physical activity, dietary monounsaturated fats, and dietary fibers from cellulose were inversely associated with risk; saturated fats were a risk factor and the association appeared stronger for men than for women, suggesting that a sedentary lifestyle and a diet rich in animal fats and refined sugars are significant risk factors.
A similar protective effect was noted in gallstone patients supplemented with dietary fish oil (n-3 polyunsaturated fatty acids, or PUFAs); oral supplementation with 11 g of n-3 PUFA per day for 6 weeks has been demonstrated to ameliorate bile composition and to maintain the cholesterol saturation index and cholesterol crystallization time of women undergoing rapid weight loss on a hypocaloric diet (1,200 kcal per day). These are human clinical studies, but they involve relatively small populations and should be characterized as preliminary.
6.3 Dietary Fiber
In a case-control study of gallstone disease, patients diagnosed with GSD had higher mean age, consumed more fat, and were more likely to be female, but they had less physical activity, total, and insoluble dietary fiber intake compared with controls. In the crude model of that study, only insoluble fiber intake showed a significant association with the risk of gallstone disease (OR T3 vs. T1 = 0.54; 95% CI: 0.3–0.9, P for trend <0.001). The overall evidence for dietary fiber as a protective factor is consistent across multiple observational studies, though causality is difficult to establish given confounding variables.
6.4 Fruits and Vegetables
A systematic review and meta-analysis on fruit and vegetable consumption enrolled 153,752 subjects, including 33,983 with gallstones, across studies with follow-up durations ranging from 1 to 20 years. Evidence from nutritional epidemiology in that meta-analysis suggests that fruit and vegetable consumption is related to a decreased risk of gallstone disease.
6.5 Coffee
A systematic review with meta-analysis examined the association of coffee consumption with gallstone disease using PubMed and EMBASE databases; a random-effects model was used to compute a pooled relative risk across one case-control study and five prospective cohort studies with seven cohorts involving 227,749 participants and 11,477 gallstone disease cases. Coffee consumption was significantly associated with a reduced risk of gallstone disease (RR 0.83; 95% CI 0.76–0.89; I² = 35.9%) based on prospective studies; an inverse relation was specifically observed in females but not in males. In a dose-response analysis, for people who drank 2, 4, and 6 cups of coffee per day, the estimated relative risks of gallstone disease were 0.89, 0.81, and 0.75, respectively, compared with the lowest level drinkers.
Coffee intake appears to decrease cholesterol crystallization in bile, thereby preventing gallstone formation and modulating inflammation associated with the presence of gallstones. Decaffeinated coffee was not associated with a decreased risk in the prospective study of US men, implicating caffeine as the active component. Evidence from observational studies is consistent but cannot fully establish causality.
6.6 Moderate Alcohol Consumption
Physical activity, moderate alcohol drinking, coffee consumption, and the intakes of some plant foods such as nuts, fruits, and vegetables, as well as fiber and polyunsaturated and monounsaturated fats, have been associated with lower gallstone risk in prospective studies. Consumption of simple sugars and saturated fat has been mostly associated with a higher risk, while fiber intake and moderate consumption of alcohol consistently reduce the risk. The mechanism by which moderate alcohol may reduce gallstone risk is not fully elucidated; evidence remains epidemiological and observational.
7. Nutrients Studied in Relation to Gallstone Disease
7.1 Vitamin C (Ascorbic Acid)
Scientific Evidence:
Cholesterol is converted to bile acids in the liver, and the rate-limiting process depends on vitamin C concentration in the hepatocytes; vitamin C increases the rate of 7α-hydroxylation of cholesterol, a reaction that is decreased in ascorbic acid deficiency, resulting in reduced bile acid biogenesis; supersaturation of bile with cholesterol precedes the formation of cholesterol gallstones, and this can be caused by a low rate of cholesterol-7α-hydroxylation.
A population-based observational study of 2,129 subjects aged 18–65 years randomly selected from the general population in southern Germany, using abdominal ultrasound, a standardized questionnaire, and blood tests, found a gallstone prevalence of 7.8% overall; subjects reporting vitamin C supplementation showed a prevalence of only 4.7%, compared with those not reporting supplementation. The authors concluded that regular vitamin C supplementation might exert a protective effect on the development of gallstones.
A small human clinical study examined the possible effects of vitamin C in 16 consecutive gallstone patients scheduled for laparoscopic cholecystectomy who were treated with vitamin C (500 mg, four times a day) for 2 weeks before surgery; plasma vitamin C concentration increased by 42% in the treatment group; the relative concentrations of plasma lipids did not differ, but the relative concentration of phospholipids was slightly higher in the treated group, the bile acid composition was changed, and the nucleation time was significantly longer in the treatment group (7 days) compared with the untreated group (2 days). This was a small, uncontrolled clinical study; findings are preliminary.
7.2 Magnesium
Some studies indicate that dietary magnesium may help reduce the formation of gallstones. Higher dietary magnesium intake is linked to a meaningfully lower chance of developing gallstones; a large population study found that people with greater magnesium intake had 42% lower odds of having gallstones compared to those with lower intake, after adjusting for other risk factors. The evidence for magnesium is largely from observational and epidemiological studies; no randomized controlled trials specifically on magnesium supplementation and gallstone incidence have been robustly identified in the peer-reviewed literature.
7.3 Vitamin E
Research has found an inverse association between circulating vitamin E levels and gallstone disease: people with higher vitamin E in their blood are less likely to develop gallstones. Some studies indicate that vitamin E may help reduce the formation of gallstones. The existing evidence is primarily observational and cross-sectional; controlled supplementation trials directed specifically at gallstone incidence are lacking.
7.4 Omega-3 Polyunsaturated Fatty Acids
Omega-3 fatty acids directly change the composition of bile in ways that make gallstones less likely to form; in one study of healthy men taking 1.5 grams of omega-3s daily for six weeks, biliary cholesterol concentration dropped by 25%. A similar effect was noted in gallstone patients supplemented with dietary fish oil (n-3 PUFAs), though cholesterol crystallization time was unchanged in that study. The human evidence is of preliminary strength, drawn from small trials; larger randomized controlled trials are needed.
7.5 B Vitamins, Carotenoids, Zinc, Copper
Some studies indicate that carotenoids, B vitamins, zinc, and copper may help reduce the formation of gallstones. However, the evidence for each of these is limited and largely indirect — derived from observational associations or population nutrition surveys. Specific controlled clinical studies linking supplementation with gallstone incidence are not yet established in the peer-reviewed literature.
8. Herbs and Natural Ingredients: Traditional Use and Scientific Evidence
8.1 Milk Thistle (Silybum marianum)
Traditional Use:
Milk thistle (Silybum marianum) is a member of the aster or daisy family and has been used by ancient physicians and herbalists to treat a range of liver and gallbladder diseases and to protect the liver against a variety of poisons. Its use is rooted in centuries of folk medicine, particularly in Europe and the Mediterranean region, primarily for liver and gallbladder conditions including gallstones. Traditional herbalists believed that milk thistle's active compounds, particularly silymarin, help to stimulate bile flow and support detoxification processes, thought to aid in preventing the formation of gallstones or supporting their passage.
Scientific Evidence:
Milk thistle is a flowering herb related to the daisy and ragweed family; people have traditionally used it for problems with the liver and gallbladder. It is sometimes used as a natural treatment for cirrhosis, jaundice, viral hepatitis, and gallbladder disorders, and there is conflicting research on the benefits of milk thistle for liver health; it may have protective effects on the liver, and there is some evidence it can help treat cirrhosis and chronic hepatitis, but experts say the evidence is not clear. In summary, while milk thistle is traditionally used for gallbladder health and is sometimes recommended for gallstones in complementary medicine, there is insufficient scientific evidence to strongly support these uses; the overall quality and quantity of evidence for its efficacy in gallstone management are low, and its use for this purpose remains primarily traditional rather than evidence-based.
8.2 Artichoke Leaf (Cynara scolymus)
Traditional Use:
The use of artichoke leaf extract in gastroenterology is based on its strong antidyspeptic effect, mediated by choleretic activity. Artichoke has long been used in European traditional herbal practice as a liver and gallbladder tonic.
Scientific Evidence:
Based on recent basic and clinical investigations, the extract of artichoke (Cynara scolymus) leaf has been revealed to possess hepatoprotective and cholesterol-reducing properties. In a randomized double-blind clinical trial, 60 consecutive patients with non-alcoholic steatohepatitis (NASH) received Cynara scolymus extract (as 6 tablets per day consisting of 2,700 mg of herb extract) or placebo for two months; improvements in liver enzymes were observed, and the levels of triglycerides and cholesterol were significantly reduced in the treatment group compared to placebo. This was a trial focused on NASH rather than gallstones specifically; direct evidence for gallstone prevention or dissolution from artichoke leaf extracts in humans remains limited. Evidence is preliminary.
8.3 Turmeric/Curcumin (Curcuma longa)
Traditional Use:
Although the therapeutic use of Curcuma was recorded as early as 1748, the first article referring to the use of curcumin in human disease was published in 1937. In Ayurvedic and traditional Indian medicine, turmeric has been used for digestive complaints, liver support, and biliary disorders. Turmeric (Curcuma longa), a popular spice in Ayurvedic medicine containing curcumin, acts as a mild cholagogue that supports bile production and flow, aiding in digestion and liver function.
Scientific Evidence:
An early clinical report examined the effects of a curcumin-containing preparation in human biliary diseases; intravenous injection of a 5% sodium curcumin solution in healthy persons was associated with rapid emptying of the gallbladder, and oral administration for 3 weeks showed notably good results against cholecystitis in 67 patients. However, this was a historical study with significant methodological limitations by contemporary standards.
A more recent animal study (using high-fat diet-fed hamsters) investigated whether curcumin supplementation reduced the bile cholesterol saturation index (CSI); unlike the curcumin-treated group whose gallbladders appeared clear and transparent, the HFD-fed group's gallbladders appeared more turbid, and curcumin supplementation markedly increased bile total bile acids and phospholipid levels and decreased bile total cholesterol concentration, decreasing the bile CSI from 1.64 to 1.08. This is animal-model evidence; its direct applicability to human gallstone disease has not been confirmed in adequately powered clinical trials.
A small but growing number of clinical trials have examined the effects of curcumin on chronic liver diseases, including gallstone disease (for example, gallbladder hypocontractility) and biliary dyskinesia; however, to date, curcumin has not become a mainstream or approved therapy for these indications. Overall, the evidence for curcumin in human gallstone disease is characterized as preliminary, drawn from small and older clinical studies and animal/in vitro data.
8.4 Dandelion (Taraxacum officinale)
Traditional Use:
Dandelion root has a long history of use in European, Native American, and East Asian herbal traditions as a bitter tonic and choleretic — to stimulate bile flow from the liver and gallbladder. Herbs like dandelion, artichoke, and gentian have traditional use for supporting bile release into the small intestine.
Scientific Evidence:
Robust, peer-reviewed human clinical trials specifically assessing dandelion root's effect on gallstone formation or gallbladder health are absent from the current literature. While dandelion is among the proposed natural remedies for gallstones, no natural treatments — including dandelion — are well-established as effective for gallstones; their actual impact on gallstones remains uncertain. The tradition of use is plausible given the herb's bitter compounds, but scientific evidence is insufficient to draw clinical conclusions.
8.5 Peppermint (Mentha piperita) and Other Proposed Botanicals
Traditional Use:
Peppermint has been used in European and folk herbal medicine as a carminative and to relieve digestive discomfort associated with the biliary system. Boldo and fumitory have also been used historically as choleretics in South American and Mediterranean traditions, respectively.
Scientific Evidence:
Among other proposed natural treatments for gallstones are peppermint, boldo, fumitory, and greater celandine, alongside dandelion root, artichoke leaf, and milk thistle. These herbs are thought to work by causing the gallbladder to contract, thereby expelling its stones; however, such an effect is not always positive, as expelled stones might become lodged in the duct of the gallbladder or the common bile duct. The scientific evidence base for peppermint, boldo, and fumitory specific to gallstone disease is preliminary and based largely on traditional use and in vitro data, without established human clinical trials.
9. Lifestyle Factors
9.1 Physical Activity
Physical activity has been associated with lower gallstone risk across epidemiological studies. Abdominal obesity, smoking, and dietary factors such as saturated fat, trans fat, and heme iron have been identified as risk factors for symptomatic gallstone disease. Sedentary behavior contributes to gallbladder stasis and metabolic dysfunction, both of which are mechanistically linked to gallstone formation. A population-based case-control study found that a sedentary lifestyle, combined with a diet rich in animal fats and refined sugars and poor in vegetable fats and fibers, represents a significant risk factor for gallstone formation.
9.2 Obesity and Body Weight
Obesity is an important risk factor for gallstone disease, more so for women than for men, raising the risk of cholesterol gallstones by increasing biliary secretion of cholesterol as a result of an increase in HMG-CoA reductase activity. Rapid weight loss is also recognized as a modifiable risk factor — very low-calorie diets and bariatric surgery accelerate bile cholesterol saturation. Omega-3 PUFA supplementation has been studied to maintain the cholesterol saturation index and cholesterol crystallization time of women undergoing rapid weight loss on a hypocaloric diet.
9.3 Gut Microbiota
The role of gut microbiota dysbiosis in gallstone formation has attracted growing research attention as part of the relationship between metabolic syndrome and gallstone disease. Altered gut microbiota is among the additional factors implicated in the pathogenesis of cholesterol gallstone disease. Emerging evidence highlights the pivotal role of the gut microbiota in regulating host metabolism; gut dysbiosis alters the production of critical metabolites, including short-chain fatty acids, bile acids, indole derivatives, and trimethylamine N-oxide, which influence intestinal barrier integrity, inflammatory pathways, and glucose homeostasis.
Altered microbial regulation of bile-acid metabolism has been implicated in impaired lipid and glucose signaling, reinforcing the relevance of FXR- and TGR5-mediated pathways in insulin resistance — both of which are connected to gallstone risk.
9.4 Oxidative Stress
Environmental factors and dietary habits, such as high-fat diets, low fiber intake, and adverse lifestyle choices (e.g., smoking and lack of exercise), indirectly influence the risk of gallstone formation by altering bile metabolism and oxidative stress levels in the body. The role of antioxidant nutrients (vitamin C, vitamin E, carotenoids) in reducing gallstone risk is consistent with this mechanism, though direct evidence from clinical trials remains preliminary.
9.5 Hormonal Factors
Estrogen treatment, pregnancy, and diabetes are consistently associated with higher gallstone risk. Estrogen promotes cholesterol secretion into bile and reduces gallbladder motility. The higher prevalence of gallstones in women compared to men is at least partly attributable to these hormonal effects.
References
Go back